Meet Gunnar—a bright, resilient young boy whose journey with hereditary spastic paraplegia is reshaping the future of advanced therapies. Diagnosed after years of uncertainty, Gunnar is now at the forefront of a groundbreaking antisense oligonucleotide (ASO) therapy designed specifically for his condition.
This powerful story reminds us why we do what we do at Cytiva: to support biopharma innovators in bringing transformative therapies to patients who need them most. From diagnosis to hope, Gunnar’s journey is a testament to the power of science, collaboration, and heart.
💙 Watch now to see how science becomes personal.
🔬 Learn more about how Cytiva can help you optimize your oligotherapeutic and deliver it safely and effectively to patients like Gunnar:
👉
https://www.cytiva.com/oligo#GeneticMedicine #OligonucleotideTherapy #PatientStory #Cytiva #BiotechInnovation #RareDiseaseAwareness #ASO #Biopharma #GeneTherapy #HopeThroughScience
